These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15023144)

  • 1. Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival.
    Nanji SA; Hancock WW; Anderson CC; Adams AB; Luo B; Schur CD; Pawlick RL; Wang L; Coyle AJ; Larsen CP; Shapiro AM
    Am J Transplant; 2004 Apr; 4(4):526-36. PubMed ID: 15023144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICOS-Dependent and -independent functions of memory CD4 T cells in allograft rejection.
    Zhang QW; Rabant M; Schenk A; Valujskikh A
    Am J Transplant; 2008 Mar; 8(3):497-506. PubMed ID: 18294146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection.
    Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Yagita H; Turka LA; Sayegh MH
    Am J Transplant; 2005 Jan; 5(1):31-9. PubMed ID: 15636609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.
    Ozkaynak E; Gao W; Shemmeri N; Wang C; Gutierrez-Ramos JC; Amaral J; Qin S; Rottman JB; Coyle AJ; Hancock WW
    Nat Immunol; 2001 Jul; 2(7):591-6. PubMed ID: 11429542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.
    Harada H; Salama AD; Sho M; Izawa A; Sandner SE; Ito T; Akiba H; Yagita H; Sharpe AH; Freeman GJ; Sayegh MH
    J Clin Invest; 2003 Jul; 112(2):234-43. PubMed ID: 12865411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICOS/B7RP-1 interference in mouse kidney transplantation.
    Lutz J; Lu R; Strobl M; Huang H; Deng M; Wang M; Ouyang N; Heemann U
    Transplantation; 2007 Jul; 84(2):223-30. PubMed ID: 17667814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator.
    Nakamura Y; Yasunami Y; Satoh M; Hirakawa E; Katsuta H; Ono J; Kamada M; Todo S; Nakayama T; Taniguchi M; Ikeda S
    Transplantation; 2003 Apr; 75(8):1115-8. PubMed ID: 12717187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse.
    Nabeyama K; Yasunami Y; Toyofuku A; Nakano M; Satoh M; Matsuoka N; Ono J; Kamada M; Uede T; Todo S; Ikeda S
    Transplantation; 2004 Dec; 78(11):1590-6. PubMed ID: 15591946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible costimulatory molecule-B7-related protein 1 interactions are important for the clonal expansion and B cell helper functions of naive, Th1, and Th2 T cells.
    Smith KM; Brewer JM; Webb P; Coyle AJ; Gutierrez-Ramos C; Garside P
    J Immunol; 2003 Mar; 170(5):2310-5. PubMed ID: 12594252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
    Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
    Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection.
    Kashizuka H; Sho M; Nomi T; Ikeda N; Kuzumoto Y; Akashi S; Tsurui Y; Mizuno T; Kanehiro H; Yagita H; Nakajima Y; Sayegh MH
    Transplantation; 2005 May; 79(9):1045-50. PubMed ID: 15880041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of ICOS-B7RP-1 costimulatory pathway in the regulation of immune responses to Leishmania major and Nippostrongylus brasiliensis infections.
    Miyahira Y; Akiba H; Ogawa SH; Ishi T; Watanabe S; Kobayashi S; Takeuchi T; Aoki T; Tezuka K; Abe R; Okumura K; Yagita H; Watanabe N
    Immunol Lett; 2003 Oct; 89(2-3):193-9. PubMed ID: 14556978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand).
    Wahl P; Schoop R; Bilic G; Neuweiler J; Le Hir M; Yoshinaga SK; Wüthrich RP
    J Am Soc Nephrol; 2002 Jun; 13(6):1517-26. PubMed ID: 12039981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
    Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.